[HTML][HTML] Clinical outcomes associated with SARS-CoV-2 Omicron (B. 1.1. 529) variant and BA. 1/BA. 1.1 or BA. 2 subvariant infection in Southern California
Epidemiologic surveillance has revealed decoupling of Coronavirus Disease 2019 (COVID-19)
hospitalizations and deaths from case counts after emergence of the Omicron (B.1.1.529…
hospitalizations and deaths from case counts after emergence of the Omicron (B.1.1.529…
Clinical outcomes among patients infected with Omicron (B. 1.1. 529) SARS-CoV-2 variant in southern California
Background The Omicron (B.1.1.529) variant of SARS-CoV-2 has rapidly achieved global
dissemination, accounting for most infections in the United States by December 2021. Risk of …
dissemination, accounting for most infections in the United States by December 2021. Risk of …
Prevention of coronavirus disease 2019 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae …
…, KJ Bruxvoort, H Fischer, VX Hong… - The Journal of …, 2022 - academic.oup.com
Background While secondary pneumococcal pneumonia occurs less commonly after
coronavirus disease 2019 (COVID-19) than after other viral infections, it remains unclear whether …
coronavirus disease 2019 (COVID-19) than after other viral infections, it remains unclear whether …
Effectiveness of 13-valent pneumococcal conjugate vaccine against medically attended lower respiratory tract infection and pneumonia among older adults
…, KJ Bruxvoort, H Fischer, VX Hong… - Clinical Infectious …, 2022 - academic.oup.com
Background Among older adults, 13-valent pneumococcal conjugate vaccine (PCV13) has
been found efficacious against nonbacteremic pneumonia associated with vaccine-serotype …
been found efficacious against nonbacteremic pneumonia associated with vaccine-serotype …
Effectiveness of pneumococcal conjugate vaccination against virus-associated lower respiratory tract infection among adults: a case-control study
JA Lewnard, KJ Bruxvoort, VX Hong… - The Journal of …, 2023 - academic.oup.com
Background Interactions of Streptococcus pneumoniae with viruses feature in the pathogenesis
of numerous respiratory illnesses. Methods We undertook a case-control study among …
of numerous respiratory illnesses. Methods We undertook a case-control study among …
[HTML][HTML] Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study
Background Respiratory pathogens, including SARS-CoV-2, can cause pulmonary structural
damage and physiologic impairment, which may increase the risk of subsequent lower …
damage and physiologic impairment, which may increase the risk of subsequent lower …
[HTML][HTML] Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA. 1 …
SY Tartof, JM Slezak, L Puzniak, V Hong… - The Lancet …, 2023 - thelancet.com
Background The SARS-CoV-2 omicron (B.1.1.529 BA.1) lineage was first detected in November,
2021, and is associated with reduced vaccine effectiveness. By March, 2022, BA.1 had …
2021, and is associated with reduced vaccine effectiveness. By March, 2022, BA.1 had …
Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization
SY Tartof, L Qian, V Hong, R Wei… - Annals of internal …, 2020 - acpjournals.org
Background: Obesity, race/ethnicity, and other correlated characteristics have emerged as
high-profile risk factors for adverse coronavirus disease 2019 (COVID-19)–associated …
high-profile risk factors for adverse coronavirus disease 2019 (COVID-19)–associated …
Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a …
SY Tartof, JM Slezak, L Puzniak, V Hong… - The Lancet …, 2022 - thelancet.com
Background The duration of protection against the omicron (B.1.1.529) variant for current
COVID-19 vaccines is not well characterised. Vaccine-specific estimates are especially needed…
COVID-19 vaccines is not well characterised. Vaccine-specific estimates are especially needed…
[HTML][HTML] Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system
KJ Bruxvoort, LS Sy, V Hong, B Lewin, L Qian, X Huang… - Vaccine, 2023 - Elsevier
… individuals who became ≥12 years old on date X between September 2, 2022 and October
11, 2022, the index date was defined as date X; for all other individuals who were aged ≥5 …
11, 2022, the index date was defined as date X; for all other individuals who were aged ≥5 …